Review
doi: 10.1016/s1357-4310(00)01759-7.
Secretases as targets for the treatment of Alzheimer's disease
Affiliations
- PMID: 11006528
- DOI: 10.1016/s1357-4310(00)01759-7
Item in Clipboard
Review
Secretases as targets for the treatment of Alzheimer's disease
Mol Med Today.
2000 Oct.
Abstract
Alzheimer's disease (AD) is the major cause of dementia in most developed countries. Treatment to modify this disease is currently unavailable, but needed urgently. The amyloid-cascade hypothesis proposes that amyloid beta-peptide (Abeta), found in the plaques characteristic of AD, plays an early, critical role in the disease process. It follows that preventing the generation of Abeta could be therapeutically useful in all cases of AD. Inhibition of the secretases that produce Abeta from a large precursor protein is the main approach to achieve this goal.
Similar articles
-
Potential novel targets for Alzheimer pharmacotherapy: I. Secretases.J Clin Pharm Ther. 2002 Jun;27(3):169-83. doi: 10.1046/j.1365-2710.2002.00415.x. J Clin Pharm Ther. 2002. PMID: 12081630 Review.
-
[Secretases as therapeutic targets for the treatment of Alzheimer's disease].Verh K Acad Geneeskd Belg. 2004;66(1):29-58; discussion 58-9. Verh K Acad Geneeskd Belg. 2004. PMID: 15074081 Review. German.
-
The inhibition of gamma-secretase as a therapeutic approach to Alzheimer's disease.Drug News Perspect. 2004 Jun;17(5):321-5. doi: 10.1358/dnp.2004.17.5.829036. Drug News Perspect. 2004. PMID: 15334182 Review.
-
The development of anti-amyloid therapy for Alzheimer's disease : from secretase modulators to polymerisation inhibitors.CNS Drugs. 2005;19(12):989-96. doi: 10.2165/00023210-200519120-00002. CNS Drugs. 2005. PMID: 16332141 Review.
-
[Secretases as targets for the treatment of Alzheimer's disease].Sheng Li Ke Xue Jin Zhan. 2003 Apr;34(2):189-92. Sheng Li Ke Xue Jin Zhan. 2003. PMID: 12889164 Review. Chinese. No abstract available.
Cited by
-
Paeonol Protects Memory after Ischemic Stroke via Inhibiting β-Secretase and Apoptosis.Evid Based Complement Alternat Med. 2012;2012:932823. doi: 10.1155/2012/932823. Epub 2012 Mar 13. Evid Based Complement Alternat Med. 2012. PMID: 22474531 Free PMC article.
-
Therapeutic approaches to age-associated neurocognitive disorders.Dialogues Clin Neurosci. 2001 Sep;3(3):191-213. doi: 10.31887/DCNS.2001.3.3/rohara. Dialogues Clin Neurosci. 2001. PMID: 22033831 Free PMC article.
-
A physically-modified saline suppresses neuronal apoptosis, attenuates tau phosphorylation and protects memory in an animal model of Alzheimer's disease.PLoS One. 2014 Aug 4;9(8):e103606. doi: 10.1371/journal.pone.0103606. eCollection 2014. PLoS One. 2014. PMID: 25089827 Free PMC article.
-
Cinnamon and Its Metabolite Sodium Benzoate Attenuate the Activation of p21rac and Protect Memory and Learning in an Animal Model of Alzheimer's Disease.PLoS One. 2015 Jun 23;10(6):e0130398. doi: 10.1371/journal.pone.0130398. eCollection 2015. PLoS One. 2015. PMID: 26102198 Free PMC article.
-
Mass spectrometry-based screening for inhibitors of beta-amyloid protein aggregation.Anal Chem. 2005 Nov 1;77(21):7012-5. doi: 10.1021/ac050556a. Anal Chem. 2005. PMID: 16255603 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical